Skip to main content
. Author manuscript; available in PMC: 2015 Jun 9.
Published in final edited form as: Anesth Analg. 2011 Sep 2;113(4):834–842. doi: 10.1213/ANE.0b013e31822c9a44

Table 1.

Patient Demographics

Naloxone infusion
rate (µg/kg/h)		 No. of subjects
(success/failure)		 Age (y)
(mean ± SEM)		 Sex,
male/female		 Posterior spine fusion/
pectus excavatum		 Cause of failure
0.05 5 (3/2) 12.7 ± 2.5 3/2 3/2 P × 1, N/V and P × 1
0.10 5 (3/2) 16.9 ± 1.3 3/2 1/4 P × 2
0.15 11 (9/2) 15.0 ± 2.1 5/6 10/1 P × 2
0.25 4 (2/2) 13.6 ± 2.0 0/4 4/0 P × 1, N/V × 1
0.40 8 (6/2) 15.1 ± 1.5 3/5 7/1 P × 1, N/V × 1
0.65 5 (3/2) 13.3 ± 1 3/2 2/3 P × 2
1 11 (10/1) 14.2 ± 2.5 7/4 9/2 N/V × 1
1.65 10 (10/0) 13.8 ± 2.3 0/10 10/0 None
P × 9
Overall 59 (46/13) 14.4 ± 2.2 24/35 36/13 N/V × 3
N/V and P × 1

N/V = nausea/vomiting; P = pruritus.